Help advance myasthenia gravis research.

Help build an A.I. model to predict myasthenia gravis symptom patterns and flares.

Watch video

At a glance

Myasthenia gravis (MG) is a neurological disease that can lead to impaired speech, blurred vision, difficulty swallowing, and other symptoms. New research using artificial intelligence and smartphone technology could help speed up diagnosis and predict symptom flares faster in the future, so that those with the disease can act quickly and get care when it’s most crucial.

Status:

Enrolling now

Commitment:

15 – 35 minutes a week

Compensation:

$250 in Amazon Gift Cards
Personalized symptom/health data visualizations

Location:

Smartphone-based at-home trial for U.S. residents.

Length:

3 months

This at-home digital health trial for myasthenia gravis will assess participant-driven data collection using smartphone modules to characterize myasthenia gravis symptoms and develop an A.I. model to predict flares.

If you've been diagnosed with MG and have a smartphone, we invite you to take a quick survey to see if you’re eligible to participate in this trial. Note that the entire trial is conducted from your own phone.

I'm interested

How it works

Participants will complete a short daily survey,  provide audio and video recordings twice a week, and keep a weekly video journal. As an option, participants can also connect additional health information, like exercise and diet, to provide a more complete picture of their health during the course of the trial.

New research using artificial intelligence and smartphone technology could help identify patterns and predict symptom flares in individuals suffering from myasthenia gravis. This could mean that people can get treatment faster, minimizing the impact of MG on their daily lives.”

Help advance myasthenia gravis research.

I'm interested

Participant eligibility

Must have a documented diagnosis of myasthenia gravis

Must have ocular (eye drooping) and/or bulbar (speech) symptoms

Must be over the age of 18

Must reside in the U.S. for the duration of the study

Must be able to read, understand and write in English

Must have a smartphone to support the doc.ai app (iOS or Android)

Additional information

Trial title

A digital health trial that assesses participant-driven data collection using smartphone modules to characterize myasthenia gravis symptoms and develop an A.I. model to predict flares

Participants

100 participants diagnosed with myasthenia gravis

Research sponsor

doc.ai

Funding provided by

UCB Biopharma (SRL)

Principal investigator

Sandra Steyaert, PhD
doc.ai

Medical expert

Yuen So, MD, PhD

Speech pathologist

Sarah Stranberg, Senior Speech-Language Pathologist

Protocol

DOC-005-2020

Instiutional Review Board

Salus IRB

Common questions

Is this trial right for me?

If you have a smartphone, a diagnosis of MG, and an interest in advancing research, please take the pre-screener to see if you qualify.

Will I have to take any medications?

You won’t be asked to take any medications that you don’t already take.

What version of iOS or Android do I need to have in order to participate?

Require iOS 10 or later, Android 5.1 or later.

What is the time commitment of the trial?

You’ll be expected to spend about 15 - 35 minutes a week between your twice weekly video check-ins and survey responses and your weekly video journal entries for three months.

Who are you recruiting for this trial?

The recruitment tool for this trial was developed for diversity, fairness, and inclusion. We aim to ensure diversity in the demographics of the trial to better understand the health needs of different populations.

Help advance myasthenia gravis research.

I'm interested